CD4 and neoplasm: The main adaptive immune response to kill tumor cells begins with recognizing tumor antigen via antigen-presenting cells (APCs), which further present tumor-associated antigens by MHC II molecules to the T cell receptors (TCRs) of CD4 helper T (Th) cells.